2-Cyclopropyl-5-nitro-1h-indole

Catalog No. :
ACNQAF592
CAS No. :
952664-85-6
Molecular Formula :
C11H10N2O2
Molecular Weight :
202.21

IUPAC Name:2-cyclopropyl-5-nitro-1H-indole

2-Cyclopropyl-5-nitro-1h-indole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$388.00Login to see priceIn stockInquiry
250mg97%$619.00Login to see priceIn stockInquiry
500mg97%$1031.00Login to see priceIn stockInquiry
1g97%$1547.00Login to see priceIn stockInquiry
5g97%$4639.00Login to see priceInquiryInquiry
10g97%$7731.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Cyclopropyl-5-nitro-1h-indole
IUPAC Name2-cyclopropyl-5-nitro-1H-indole
MDL No.0
Molecular FormulaC11H10N2O2
Molecular Weight202.21
SMILESO=[N+](C1=CC2=C(NC(C3CC3)=C2)C=C1)[O-]
InChI KeyNCVBOWNCUZNLBX-UHFFFAOYSA-N
Synonym2-cyclopropyl-5-nitro-1H-indole | 952664-85-6 | SCHEMBL1465497 | MFCD17198194 | AS-79579 | C93199
CAS No.952664-85-6
PubChem CID59129442

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACNQAF592 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAWBD401 route compound structure diagram
    ACAWBD4017774-34-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNQAF592 route product structure diagram
    ACNQAF592952664-85-6 In Stock
Inquiry

2. ACNQAF592 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAQNU854 route compound structure diagram
    ACAQNU854411235-57-9 In Stock
  4. Then
  5. ACNQAF592 route product structure diagram
    ACNQAF592952664-85-6 In Stock
Inquiry

Comments (0)